Skip to content

Author

Neha Singh

We have 4 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Pathophysiology and Pharmacological Management of Chronic Liver Injury: Current Challenges and Future Directions.

INTRODUCTION Chronic liver injury results from persistent hepatic injuries such as metabolic disorders, alcohol consumption, viral infections, drug toxicity, autoimmune conditions, and genetic factors. It is a major global health concern due to its progression to fibrosis, cirrhosis, and hepatocellular carcinoma. This...

Naziya Parveen, Mayank Kumar, Monojit Das et al. · 0 citations
Review Sep 2026

Advances in the Inflammatory and Immune-mediated Kidney Disorders (IMKD): From Pathogenesis to Precision Therapy.

INTRODUCTION Inflammatory and immune-mediated kidney disorders (IMKD) comprise a diverse group of renal diseases and are a leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide. Despite advancements in supportive care, longterm renal outcomes remain suboptimal due to disease heterog...

S. Singh, A. Patel, Dharmendra Kumar et al. · 0 citations
Review Sep 2026

Unveiling the Phytoconstituents and Health Benefits of Carica papaya L.: From Traditional Medicine to Modern Therapeutics.

INTRODUCTION The tropical plant Carica papaya L., which is a member of the Caricaceae family, is well known for its medicinal and nutritional qualities. The plant's leaves, fruits, seeds, and latex have all historically been used to treat inflammatory diseases, cancer, metabolic abnormalities, and infections. The objec...

P. Goswami, Saloni Kumari, Qumar Negar et al. · 0 citations
Review Sep 2026

Influence of Major Histocompatibility Complex (MHC) Diversity on Immune Modulation, Pathogenesis, and Control of Lumpy Skin Disease Virus.

Current evidence indicates that effective LSDV control requires integration of molecular diagnostics, vector management, vaccination, and host immunogenetics, and BoLAguided immunoinformatics provides promising opportunities for developing multi-epitope vaccines, although experimental validation remains essential.

Siddhant Krishna, Qumar Negar, P. Goswami et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.